The information below compares Q3 2024 ended December 31st, 2023 with Q2 2023 and all figures are in Canadian dollars. Go to convert into another currency.
Q3 Financial Highlights
-
- Adj. Gross Margin: UP to 50% from 44%
-
Medical: UP 3.0% to $45.1M
- Adj. Gross Margin: DOWN to 62% from 63%
-
Recreational: DOWN 3.3% to $11.6M
- Adj. Gross Margin: DOWN to 26% from 27%
-
Plant Propagation: UP 1.4% to $7.3M
- Adj. Gross Margin: DOWN to 18% from 22%
Q3 Operational Highlights
Management Commentary
Miguel Martin, Chief Executive Officer, said:
“Fiscal 2024 is on track to be our strongest to date, driven by the continued strength of our differentiated business model and our focus on profitable global medical cannabis markets.
…Q3 marks our fifth consecutive quarter of positive adjusted EBITDA, driven by consistent performance in our Canadian business and substantial revenue growth internationally…”
Fiscal Q4 Expectations
Stock Performance
Aurora’s () stock price went DOWN 18.6% during Q3 (October – December) and has declined a further 18.8% as of mid-day today since then.More By This Author:
